Mira Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

• Mira Pharmaceuticals Inc MIRA.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -11 cents. The mean expectation of two analysts for the quarter was for a loss of 13 cents per share. Wall Street expected results to range from -15 cents to -11 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Mira Pharmaceuticals Inc's reported EPS for the quarter was a loss of 9 cents​.

• The company reported a quarterly loss of $1.54 million.

• Mira Pharmaceuticals Inc shares had risen by 21.5% this quarter and gained 28.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

• Wall Street's median 12-month price target for Mira Pharmaceuticals Inc is $17.75, about 91.7% above its last closing price of $1.47

This summary was machine generated from LSEG data August 15 at 04:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)